Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Baggs

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Journal of Travel Medicine|October 15, 2013
Safety of the yellow Fever vaccine: a retrospective studyJames D Nordin, Emily D Parker, Gabriela Vazquez-Benitez, et al.
Vaccine|October 10, 2015
Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trialsJames Baggs, Kimberly Yousey-Hindes, Elizabeth Dodds Ashley, et al.
Infection Control and Hospital Epidemiology|May 7, 2021
Associations of facility-level antibiotic use and hospital-onset <i>Clostridioides difficile</i> infection in US acute-care hospitals, 2012-2018Sophia V Kazakova, James Baggs, Sarah H Yi, et al.
Epidemiology and Infection|January 17, 2022
Identification and description of patients with multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection using the Premier Healthcare DatabaseJennifer DeCuir, James Baggs, Michael Melgar, et al.
Pediatrics|December 14, 2011
Trivalent inactivated influenza vaccine is not associated with sickle cell crises in childrenSimon J Hambidge, Colleen Ross, Jason Glanz, et al.
Infection Control and Hospital Epidemiology|May 19, 2022
Trends in facility-level rates of <i>Clostridioides difficile</i> infections in US hospitals, 2019-2020Ashley N Rose, James Baggs, Sophia V Kazakova, et al.
MMWR. Morbidity and Mortality Weekly Report|December 30, 2021
COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021Anne M Hause, James Baggs, Paige Marquez, et al.
MMWR. Morbidity and Mortality Weekly Report|August 18, 2022
Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
BMC Infectious Diseases|October 7, 2009
Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink studyLisa A Jackson, Onchee Yu, Edward A Belongia, et al.
Vaccine|August 27, 2005
Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink populationLisa A Jackson, Jennifer C Nelson, Cynthia G Whitney, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Journal of Travel Medicine|October 15, 2013
Safety of the yellow Fever vaccine: a retrospective studyJames D Nordin, Emily D Parker, Gabriela Vazquez-Benitez, et al.
Vaccine|October 10, 2015
Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trialsJames Baggs, Kimberly Yousey-Hindes, Elizabeth Dodds Ashley, et al.
Infection Control and Hospital Epidemiology|May 7, 2021
Associations of facility-level antibiotic use and hospital-onset <i>Clostridioides difficile</i> infection in US acute-care hospitals, 2012-2018Sophia V Kazakova, James Baggs, Sarah H Yi, et al.
Epidemiology and Infection|January 17, 2022
Identification and description of patients with multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection using the Premier Healthcare DatabaseJennifer DeCuir, James Baggs, Michael Melgar, et al.
Pediatrics|December 14, 2011
Trivalent inactivated influenza vaccine is not associated with sickle cell crises in childrenSimon J Hambidge, Colleen Ross, Jason Glanz, et al.
Infection Control and Hospital Epidemiology|May 19, 2022
Trends in facility-level rates of <i>Clostridioides difficile</i> infections in US hospitals, 2019-2020Ashley N Rose, James Baggs, Sophia V Kazakova, et al.
MMWR. Morbidity and Mortality Weekly Report|December 30, 2021
COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021Anne M Hause, James Baggs, Paige Marquez, et al.
MMWR. Morbidity and Mortality Weekly Report|August 18, 2022
Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
BMC Infectious Diseases|October 7, 2009
Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink studyLisa A Jackson, Onchee Yu, Edward A Belongia, et al.
Vaccine|August 27, 2005
Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink populationLisa A Jackson, Jennifer C Nelson, Cynthia G Whitney, et al.
Pageof 11